pubmed.ncbi.nlm.nih.gov

Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus - PubMed

Mutational analysis of the human immunodeficiency virus type 1 Rev transactivator: essential residues near the amino terminus

T J Hope et al. J Virol. 1990 Nov.

Abstract

The expression of certain mRNAs from human immunodeficiency virus type 1 (HIV-1) is controlled by the viral transactivator Rev, a nucleolar protein that binds a cis-acting element in these mRNAs. Rev is encoded by two viral exons that specify amino acids 1 to 26 and 27 to 116, respectively. Earlier studies have mapped essential regions of the protein that are encoded in the second exon. By further mutational analysis of Rev, we have now identified a novel locus encoded by the first exon that also is essential for transactivation in vivo. Defined by mutations at residues 14 to 20, this locus coincides with a cluster of positively charged and nonpolar amino acids that is conserved in Rev proteins of all known primate immunodeficiency viruses. Rev proteins that contained mutations at this site were defective in both nuclear localization and transactivation and did not function as trans-dominant inhibitors of wild-type Rev. Fusion of these mutants to a heterologous nuclear protein complemented the defect in localization but did not restore biological activity. Our findings suggest that this N-terminal locus may play a direct role in transactivation, perhaps contributing to essential protein-protein interactions or forming part of the RNA-binding domain of Rev.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Mol Cell Biol. 1982 Sep;2(9):1044-51 - PubMed
    1. J Virol. 1990 Jun;64(6):2505-18 - PubMed
    1. Science. 1985 Feb 1;227(4686):484-92 - PubMed
    1. Cell. 1985 Jan;40(1):9-17 - PubMed
    1. Proc Natl Acad Sci U S A. 1985 Jan;82(2):488-92 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources